TIL
Instil Bio Inc.
NASDAQ: TIL · HEALTHCARE · BIOTECHNOLOGY
$7.85
-2.85% today
Updated 2026-04-29
Market cap
$54.80M
P/E ratio
—
P/S ratio
54,248.82x
EPS (TTM)
$-10.70
Dividend yield
—
52W range
$6 – $43
Volume
0.0M
Instil Bio Inc. (TIL) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+37.1%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+10.2%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-4.2%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-4.7%
2026-03-27
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-27 | $-0.97 | +74.3% | $8.36 | $7.97 | -4.7% |
| 2025-11-13 | $-2.01 | +40.7% | $14.99 | $14.42 | -3.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-3.78 | $-0.97 | +74.3% | — | — |
| 2025-09-30 | $-3.39 | $-2.01 | +40.7% | — | — |
| 2025-06-30 | $-3.01 | $-3.24 | -7.6% | — | — |
| 2025-03-31 | $-2.23 | $-1.32 | +40.8% | — | — |
| 2024-12-31 | $-3.65 | $-1.08 | +70.4% | $3.99M | -48.0% |
| 2024-09-30 | $-2.10 | $-2.55 | -21.4% | — | — |
| 2024-06-30 | $-2.98 | $-2.29 | +23.2% | — | — |
| 2024-03-31 | $-2.23 | $-3.74 | -67.7% | — | — |
| 2023-12-31 | $-2.84 | $-1.99 | +29.9% | $7.67M | — |
| 2023-09-30 | $-0.10 | $-0.52 | -420.0% | — | — |
| 2023-06-30 | $-0.16 | $-0.14 | +12.5% | — | — |
| 2023-03-31 | $-0.15 | $-0.44 | -193.3% | — | — |
Frequently asked questions
Has Instil Bio Inc. beaten earnings estimates?
Instil Bio Inc. has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +37.1% over the last 4 quarters.
How does TIL stock react to earnings?
TIL stock has moved an average of -4.2% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.